ELANIX BIOTECHNOLOGIES
Elanix Biotechnologies is a tissue regeneration company. We develop and commercialize products for acute wound care, dermatological and gynecological applications, as well as providing cell technology services. The company was founded in 2013 as a spin-out from the University Hospital of Lausanne (CHUV), Switzerland, to commercialize a patented progenitor cell technology. Progenitor cells are fully differentiated yet immunologically neutral cells that are very potent inducers of tissue growth and healing. Elanix owns GMP certified Master and Working cell banks containing vast quantities of cells. The Company is headquartered in Nyon, Switzerland with offices in Wiesbaden and listed on the Frankfurt stock exchange under the symbol ELN.
ELANIX BIOTECHNOLOGIES
Social Links:
Industry:
Biotechnology Health Care Life Science
Founded:
1994-01-01
Address:
Berlin, Berlin, Germany
Country:
Germany
Website Url:
http://www.elanixbiotechnologies.com
Total Employee:
11+
Status:
Closed
Contact:
+41225520971
Email Addresses:
[email protected]
Total Funding:
4 M EUR
Technology used in webpage:
SPF Amazon AJAX Libraries API YouTube ASP.NET IIS Amazon Virginia Region DigiCert SSL ASP.NET 4.0 IIS 8
Similar Organizations
Blue Belt Technologies
Blue Belt Technologies is a medical device company that focuses on technology and capabilities of surgical instrumentation.
Renovacor
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.
Syros Pharmaceuticals
Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Official Site Inspections
http://www.elanixbiotechnologies.com
- Host name: 68.69.185.12
- IP address: 68.69.185.12
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Elanix Biotechnologies"
elanixbiotechnologies.com – elanixbiotechnologies.com
Email: [email protected] Follow Us Stay connected with Elanix Biotechnologies on social media for the latest news, updates, and insights into the future of regenerative medicine.See details»
Elanix Biotechnologies - Crunchbase Company Profile …
Elanix Biotechnologies is a tissue regeneration company. We develop and commercialize products for acute wound care, dermatological and …See details»
Elanix Biotechnologies AG - Company Profile and News
Company profile page for Elanix Biotechnologies AG including stock price, company news, executives, board members, and contact informationSee details»
Elanix Biotechnologies - PitchBook
Elanix Biotechnologies General Information Description. Elanix Biotechnologies AG is a tissue regeneration company. It develops and commercializes …See details»
Overview, News & Similar companies - ZoomInfo.com
View Elanix Biotechnologies (www.elanixbiotechnologies.ch) location in Vaud, Switzerland , revenue, industry and description. Find related and similar companies as well as employees …See details»
Elanix Biotechnologies SA Overview | SignalHire Company Profile
Organization Website: elanixbiotechnologies.com : Contact Email [email protected] Elanix Biotechnologi... industries Biotech: Headquarters Location: Chemin du Joran, Nyon, Vaud, …See details»
Company Elanix Biotechnologies AG BOERSE DUESSELDORF
May 3, 2021 Elanix Biotechnologies AG is a Germany-based provider of solutions for tissue regeneration. The Company develops and commercializes products for acute wound care, …See details»
Company Elanix Biotechnologies Börse Stuttgart
Elanix Biotechnologies AG is a Germany-based provider of solutions for tissue regeneration. The Company develops and commercializes products for acute wound care, dermatological and …See details»
Elanix Biotechnologies - Craft
Aug 2, 2023 Elanix Biotechnologies develops and commercializes products for acute wound care, dermatological and gynecological applications. The company develops and markets …See details»
Elanix Biotechnologies SA - VentureRadar
Website: http://www.elanixbiotechnologies.com. Develops and markets progenitor cell-based products for tissue regeneration and healing in burns, gynecological, and ...See details»
Elanix Biotechnologies SA | LinkedIn
Elanix Biotechnologies SA | 422 followers on LinkedIn. Elanix Biotechnologies develops and commercializes tissue regeneration products for chronic and acute wound care, and advanced …See details»
Elanix Biotechnologies - Products, Competitors, Financials, …
Elanix Biotechnologies focuses on the development and commercialization of tissue regeneration products within the biotechnology sector. Use the CB Insights Platform to explore Elanix …See details»
Elanix Biotechnologies – Wikipedia
Das Unternehmen wurde 1994 in Erfurt unter dem Namen Porta Fenster und Türen AG als Holdinggesellschaft des gleichnamigen, 1966 als Tischlerei gegründeten Herstellers von …See details»
Elanix Biotechnologies SA - startup.ch
Elanix Biotechnologies SA: Elanix Biotechnologies SA develops and commercializes tissue regeneration products for acute and chronic wound care, and advanced skin care products for …See details»
Elanix Biotechnologies SA - Nyon, Switzerland - bionity.com
Elanixbiotechnologies.com +41 22 363 66 40. Share. Xing Linkedin Facebook X E-mail Loading... Bookmark. Bookmark list; Bookmark. Start-up. Elanix Biotechnologies SA. 1260 Nyon …See details»
Elanix Technologies SA - VentureRadar
Elanix is a Swiss Life Science company dedicated to regenerative medicine using progenitor cells stored and expanded in its own GMP validated Master... ... Find out ...See details»
Elanix Biotechnologies AG Xetra - MarketScreener.com
May 29, 2018 For more information and updates, visit www.elanixbiotechnologies.com. Follow us on Twitter @elanix_biotech Contact: Elanix Biotechnologies AG Magdalena Onyszkiewicz …See details»
Elanix Biotechnologies’s Partner Transwell Biotech Starts First ...
Jul 21, 2017 First Patient Treated in Phase I/II TWB-103 Trial Nyon, Switzerland and Potsdam, Germany, July 20, 2017 -- Elanix Biotechnologies AG (FRA: ELN), a developer of tissue …See details»
Elanix Biotechnologies Starts EU Commercialization of ... - LinkedIn
May 31, 2017 Nyon, Switzerland and Potsdam, Germany, May 31, 2017 -- Elanix Biotechnologies AG (FRA: ELN), a developer of tissue regeneration products and specialty …See details»
Elanix Biotechnologies AG (Elanix Biotechnologies AG) - 药物管线_ …
了解Elanix Biotechnologies AG (Elanix Biotechnologies AG)公司的药物管线，治疗领域，技术平台，以及它的1篇新闻，药物:ELX1-007。See details»